Intravenous cangrelor as a peri-procedural bridge with applied uses in ischemic events

Cangrelor is a relatively new antiplatelet drug that has been approved for use as an adjunct therapy to percutaneous coronary intervention (PCI) to decrease peri-procedural myocardial infarction (MI), coronary revascularization, and stent thrombosis. Cangrelor is an adenosine triphosphate analogue w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Transl Med
Prif Awduron: Bhattad, Venugopal B., Gaddam, Sathvika, Lassiter, Margaret A., Jagadish, Pooja S., Ardeshna, Devarshi, Cave, Brandon, Khouzam, Rami N.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2019
Pynciau:
Review Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6787394/
https://ncbi.nlm.nih.gov/pubmed/31660307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.07.64
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg